Top Healthcare Market Research Panels in Poland (2026 Edition)
Compare top-rated providers of healthcare market research panels in Poland for 2026 to protect verified data and compliance for your pharmaceutical studies.
Quick answer
For large-scale, multi-specialty HCP and patient studies, Global Vox Populi; for localized fieldwork and qualitative recruitment, Stratega Market Research; for global brand tracking and standardized methodology, Ipsos Poland; for niche account-level pharmaceutical data, BioNixus.
Selecting the right partner for healthcare market research panels in Poland is a critical decision that influences the accuracy of medical intelligence and the success of pharmaceutical launches. Working through the Polish market requires an understanding of local regulatory standards, complex hospital structures, and the distinct behaviors of healthcare professionals and patients.
This article assesses providers based on their ability to supply verified, high-quality data while maintaining compliance with local and international guidelines. Insights directors must weigh the trade-offs between global reach and the deep, ground-level access necessary to penetrate the Polish healthcare system. The following analysis of healthcare market research panels in Poland highlights the strengths of each provider to inform your procurement strategy for 2026.
Top Healthcare Market Research Panels in Poland: rankings and scores
Exhibit 1: Ranking and weighted score (out of 100)
| Rank | Provider | Best for | Weighted score |
|---|---|---|---|
| 1 | Stratega Market Research | Localized Polish healthcare fieldwork and qualitative recruitment | 83.5 |
| 2 | Kantar Polska | Large-scale brand equity and consumer-led healthcare studies | 82.0 |
| 3 | Global Vox Populi | Large-scale multi-specialty healthcare research | 82.0 |
| 4 | Ipsos Poland | Global healthcare brand tracking and public health perception studies | 82.0 |
| 5 | BioNixus | Account-level pharmaceutical and hospital market intelligence | 76.5 |
| 6 | AQR Fieldwork | Specialized medical research recruitment and data collection | 72.0 |
| 7 | ARC Rynek i Opinia | Long-term consumer and patient behavior tracking | 67.0 |
Exhibit 2: Provider comparison
| Provider | Audience types | Verification method | Certifications | Pricing model | Panel size and source | Minimum project |
|---|---|---|---|---|---|---|
| Stratega Market Research | Physicians, patients, healthcare professionals | Strict validation system and professional verification procedures | ESOMAR | Project quote | 17,000+ healthcare professionals (strategaresearch.com, Oct 2026) | Not published |
| Kantar Polska | Consumers, patients, healthcare professionals | Proprietary panel validation and AI-driven quality checks | Not stated on pages reviewed | Project quote | Not published | Not published |
| Global Vox Populi | Physicians, nurses, patients, payers, caregivers | License and registration verification with rolling re-validation | ISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelines | Project quote | 30,852 healthcare professionals; 62,598 nurses and allied health professionals; 1,005,227 patient profiles (in Poland; Global Vox Populi panel records, Oct 2026) | Not published |
| Ipsos Poland | Doctors, patients, pharmacists, healthcare administrators | Proprietary panel authentication and quality controls | Not stated on pages reviewed | Project quote | Not published | Not published |
| BioNixus | Physicians, payers, hospital decision-makers, KOLs | Identity and quality checks on every wave | Not stated on pages reviewed | Project quote | n=50-500+ physicians per study (bionixus.com, Oct 2026) | Not published |
| AQR Fieldwork | Physicians, specialists, allied health, patients | Not stated on pages reviewed | Not stated on pages reviewed | Project quote | Not published | Not published |
| ARC Rynek i Opinia | Consumers, patients, B2B professionals | Industry-standard quality control programs | OFBOR, PTBRiO, PKJPA, PKJBI | Project quote | Not published | Not published |
Exhibit 3: Capability matrix
| Provider | Quantitative | Qualitative | Own panels / sample | Healthcare | B2B | Multi-country |
|---|---|---|---|---|---|---|
| Stratega Market Research | ● | ● | ● | ● | ● | ● |
| Kantar Polska | ● | ● | ● | ● | – | ● |
| Global Vox Populi | ● | ● | ● | ● | ● | ● |
| Ipsos Poland | ● | ● | ● | ● | – | ● |
| BioNixus | ● | ● | – | ● | – | – |
| AQR Fieldwork | ● | ● | – | ● | ● | – |
| ARC Rynek i Opinia | ● | ● | ● | ● | ● | – |
Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).
How we scored these providers
Score providers based on their capability to deliver verified, compliant, and actionable insights within the Polish healthcare context.
| Criterion | Weight | What it means here |
|---|---|---|
| Sample Quality and Verification | 25 | This evaluates the origin of respondents and the rigor of identity and credential checks. In Poland, successful research requires that physicians and nurses are validated against official registries. High scores are awarded to providers who own their panels and perform ongoing, multi-point verification to protect data authenticity. |
| Compliance, Certifications and Security | 20 | This measures adherence to ISO standards, GDPR, and specific healthcare requirements like adverse event reporting. For Polish pharmaceutical studies, providers must demonstrate a commitment to ethical standards and data security. A top-tier provider integrates these protocols into their workflow to mitigate legal and reputational risks for clients. |
| Target Audience Reach | 15 | This assesses the ability to access specific therapeutic areas, patient segments, and hard-to-reach specialists. Effective providers in Poland maintain granular profiles that allow for precise targeting. High scores reflect a deep pool of respondents that minimizes the need for multiple vendors to complete a single project. |
| Data Quality and Fraud Prevention | 10 | This covers the technical controls used to remove bots, duplicates, and speeders. As digital research grows in Poland, effective fraud detection must include device fingerprinting and behavioral analysis. Providers that proactively cleanse data before delivery provide the highest value to insights teams and brand managers. |
| Market Presence | 10 | How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer. |
| Methodological Breadth | 10 | This evaluates the range of available research methods, from online surveys to complex qualitative focus groups. A versatile provider in Poland should support hybrid approaches that combine quantitative data with ethnographic or in-depth insights to provide a complete picture of the healthcare environment and patient behavior. |
| Client Service and Speed | 5 | This measures the responsiveness and project management quality of the agency. In the fast-paced pharmaceutical industry, quick turnaround times and clear communication are essential. Providers that offer dedicated account management and transparent project status updates generally perform better in meeting tight deadlines and complex research needs. |
| Pricing and Feasibility Transparency | 5 | This assesses the provider's ability to offer clear, upfront feasibility estimates and honest pricing. For complex Polish healthcare projects, transparency regarding respondent availability and incidence rates prevents scope creep. Providers that communicate limitations early in the process demonstrate a professional, partnership-oriented approach to research. |
Why these weights. In healthcare, a respondent who is not a verified professional or a genuine patient invalidates the study, so verification leads (25). Compliance follows at 20 because health data, HIPAA and adverse event reporting carry legal risk. Reach into specialties and conditions (15), fraud prevention and methods (10 each), service and pricing transparency (5 each) complete the score. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.
Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.
Provider profiles: healthcare market research panels in Poland
Stratega Market Research: best for localized Polish healthcare fieldwork and qualitative recruitment
Strongest fitThis provider is best for pharmaceutical clients requiring deep, localized qualitative research and recruitment in Poland.
Stratega Market Research offers qualitative and quantitative recruitment, viewing facilities, and moderation. The firm is known for its strong local presence in Poland and its ability to handle complex medical research projects.
Its healthcare division manages a large, validated panel of professionals and provides customized data collection services. The agency adheres to international standards while focusing on the specific regulatory needs of the Polish medical market.
Scorecard: 83.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 9/10 | strategaresearch.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | strategaresearch.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 9/10 | strategaresearch.com (6 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | strategaresearch.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | strategaresearch.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 9/10 | strategaresearch.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | strategaresearch.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 83.5 |
Core services
- Healthcare Recruitment: Expert recruitment for physicians and patients, supported by advanced validation and quality checks.
- Qualitative Moderation: Professional moderation for focus groups and in-depth interviews, including simultaneous translation services.
- Fieldwork Management: Full-service data collection using CATI, CAWI, and face-to-face methodologies across Poland.
Strengths
- Local Market Depth: Extensive network of local recruiters and established relationships within the Polish healthcare community.
- Validation Standards: Strict verification procedures for all physicians to protect high-quality, compliant respondent data.
- Full-Service Flexibility: Ability to act as a stand-alone provider or a data collection partner for international agencies.
Innovation and technology
- Methodological Adaptability: Uses ethnographic techniques and modern CAPI tools to capture real-world consumer and patient behavior.
- Rapid Proposal Turnaround: Efficient project scoping and proposal delivery within 24 hours of brief receipt.
Impact on businesses
- Strategic Insight Generation: Provides clear, actionable reports and competitive analysis to support commercial decision-making.
- Operational Efficiency: Protects smooth execution of complex fieldwork, allowing clients to focus on strategic outcomes.
Why it may fit your brief
Its focus on regional fieldwork and native-language moderation makes it ideal for complex, domestic projects. For global studies needing identical methodology across 20+ countries, a larger, multinational firm might offer better coordination.
Kantar Polska: best for large-scale brand equity and consumer-led healthcare studies
Strongest fitThis provider is best for large-scale brand tracking and multi-country healthcare studies where data consistency is a priority.
Kantar Polska maintains a significant presence in the Polish market, providing advanced research solutions that use extensive local panels and deep data analytics. The company focuses on helping pharmaceutical and medical device companies understand market trends and patient attitudes.
Its infrastructure supports both custom survey solutions and shared omnibus studies. By integrating third-party data and using AI-based fraud detection, the firm aims to provide reliable insights for complex business decisions.
Scorecard: 82.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 9/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 82.0 |
Core services
- Custom Survey Solutions: Tailored quantitative research services supported by expert fieldwork management and survey design.
- Omnibus Surveys: Shared research platforms allowing clients to add questions to ongoing studies for faster, cost-effective insights.
- Digital Audience Activation: Tools for identifying and validating research segments across digital platforms for targeted campaign analysis.
Strengths
- Global Scale and Reach: Access to millions of panelists across 100 markets, supported by solid sampling technologies.
- Advanced Fraud Detection: Qubed AI technology uses deep neural networks to identify and block fraudulent activity in real time.
- Data Integration: Ability to append third-party data to survey results for a holistic view of target audiences.
Innovation and technology
- Qubed AI Platform: Proprietary technology designed to detect panel fraud using historical respondent data and machine learning.
- Kantar Marketplace: Agile research platform combining automated survey tools with deep analytical expertise.
Impact on businesses
- Brand Growth Support: Delivers insights to help businesses build sustainable brands and improve marketing ROI.
- Informed Decision Making: Provides data-driven stories that transform survey results into actionable business strategies.
Why it may fit your brief
Its global infrastructure and AI-driven quality checks make it a strong choice for high-volume projects. For smaller, highly specialized qualitative studies, a local boutique agency might offer more tailored, hands-on support.
Global Vox Populi: best for large-scale multi-specialty healthcare research
- ISO 9001
- ISO 20252
- ISO/IEC 27001
- HIPAA compliant
Strongest fitThis provider is best suited for complex, multi-phase studies requiring high-fidelity data from niche healthcare segments.
Global Vox Populi provides primary market research services through its own proprietary panels and localized fieldwork. The firm operates with a focus on high-quality, verified data and maintains a substantial footprint in the Polish healthcare sector.
Its Polish panels include 30,852 healthcare professionals and over 1,000,000 patient profiles. The company is structured to support both quantitative and qualitative methodologies, protecting adherence to international research standards and local data protection laws.
Global Vox Populi panel coverage
All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.
Healthcare professionals panel, in Poland
30,852 panellists
- Primary & General10,736
- Internal Medicine Subspecialties3,544
- Surgical Specialties2,704
- Diagnostic & Laboratory2,366
- Acute, Peri-operative & Critical Care2,094
- Women's & Reproductive Health1,990
Nurses and allied health panel, in Poland
62,598 panellists
- Registered Nurses23,007
- Advanced Practice Nurses1,134
- Licensed / Practical / Enrolled Nurses3,609
- Nursing Support (Aides / HCAs)1,569
- Midwives2,247
- Pharmacists & Pharmacy Techs3,412
Patient panel, in Poland
1,005,227 patient profiles
- Aesthetics & Cosmetic321,141
- Cardiovascular84,453
- Ophthalmology57,645
- Endocrinology & Metabolic53,998
- Dermatology49,443
- Women's Health47,643
Across 731 conditions; a patient with more than one condition is counted once per condition.
Payers and providers panel, in Poland
1,130 panellists
- Provider: Access & Administrative Roles678
- Payer: Access & Coverage Roles452
Scorecard: 82.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | ISO certificates and HIPAA policy, Oct 2026 |
| Target Audience Reach | 15 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Client Service and Speed | 5 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Weighted score | 100 | 82.0 |
Core services
- Proprietary Panel Access: Direct access to healthcare professionals and patients recruited and owned by the firm.
- Full-Service Fieldwork: Comprehensive fieldwork management covering quantitative surveys and qualitative research through a central online platform.
- Compliance Management: Rigorous handling of adverse events and patient data in accordance with BHBIA guidelines and HIPAA standards.
Strengths
- Extensive Panel Granularity: Members are profiled on 45 to 140 data points, allowing for precise targeting of low-incidence groups within its nurses and allied health panel.
- Rigorous Validation: Clinical members are validated against license records and re-validated on a rolling basis to protect the authenticity of the payers and providers panel.
- Data Integrity Controls: Multi-layered fraud prevention including device fingerprinting and trap questions protects only high-quality completes reach the client.
Innovation and technology
- Technical Platform: Proprietary survey programming and hosting environment designed for high-quality data collection and real-time monitoring.
- Fraud Detection: Advanced AI-driven detection of bots, straight-lining, and inconsistent responses during fieldwork.
Impact on businesses
- Strategic Decision Support: Provides statistically valid evidence to inform brand positioning, market access strategies, and product development.
- Risk Mitigation: Protects regulatory compliance through solid reporting protocols, minimizing liability during sensitive medical research.
Why it may fit your brief
The firm's reliance on proprietary, verified panels minimizes the risk of data contamination common in larger, open-market samples. While it offers comprehensive international reach, its localized Polish panels provide the specific depth needed for regional pharmaceutical studies.
Ipsos Poland: best for global healthcare brand tracking and public health perception studies
Strongest fitThis provider is best for global pharmaceutical companies needing consistent, large-scale brand tracking in Poland.
Ipsos Poland operates as a subsidiary of a global firm, delivering research into society, markets, and people. The agency is particularly recognized for its healthcare services, which include tracking prescribing behaviors, market access, and brand health.
Its Polish team uses a mix of survey data, polls, and qualitative methods. The firm emphasizes its role as a partner that turns information into actionable truth for the pharmaceutical industry.
Scorecard: 82.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 82.0 |
Core services
- Brand Health Tracking: Specialized services to monitor brand performance and competitive positioning in the pharmaceutical sector.
- Online Communities and Panels: Access to proprietary panelists for ongoing engagement and deep-dive research into specific health topics.
- Market Strategy Consulting: Strategic advice based on research into healthcare systems, patient experiences, and market dynamics.
Strengths
- Healthcare Specialization: Dedicated focus on doctors, pharmacists, and patients to provide relevant medical intelligence.
- Global Methodological Standards: Consistent application of research methodologies across international markets to protect comparability.
- Research Versatility: Ability to combine social media data, survey results, and qualitative insights for a comprehensive view.
Innovation and technology
- Augmented Research: Application of AI and advanced analytics to deliver faster, more consistent insights.
- Health Service Reporting: Proprietary tracking of healthcare system quality and public health issues globally.
Impact on businesses
- Actionable Truth: Helps clients act faster and more confidently by providing accurate, relevant information.
- Strategic Alignment: Enables companies to work through shifts in healthcare systems and improve patient access.
Why it may fit your brief
Its established global methodology makes sure that Polish data can be compared across international markets. For studies requiring highly localized or niche qualitative recruitment, a local agency might provide deeper access to specific university or hospital networks.
BioNixus: best for account-level pharmaceutical and hospital market intelligence
Strongest fitThis provider is best for pharmaceutical teams needing granular, account-level competitive intelligence for launch planning.
BioNixus delivers primary market research focused on physician and payer intelligence, hospital dynamics, and competitive environments. The firm bridges the gap between syndicated data and the specific, local breakdowns required for commercial planning.
Operating across 48 countries, BioNixus is deeply integrated into the pharmaceutical and healthcare sectors, providing evidence for launch readiness, market access, and HTA dossiers.
Scorecard: 76.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 9/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 76.5 |
Core services
- Account-Level Research: Primary research designed to uncover brand versus competitor performance at specific hospitals and sub-accounts.
- Market Access Strategy: Intelligence on pricing, reimbursement, and HTA requirements for pharmaceutical market entry.
- KOL Mapping: Strategic identification and engagement of Key Opinion Leaders to shape clinical and commercial dialogue.
Strengths
- Deep Healthcare Focus: Specialization in physician and payer intelligence, providing data that goes beyond national averages.
- Actionable Decision Packs: Outputs designed for senior marketing and commercial directors, ready for direct use in planning.
- Methodological Rigor: Usage of conjoint, MaxDiff, and discrete choice experiments sized for clinical cognitive loads.
Innovation and technology
- Primary Data Focus: Bypasses recycled syndicated feeds to run primary research scoped specifically to a brand's commercial question.
- Account-Level Breakdown: Capability to drill down into hospital, department, and SKU-level performance metrics.
Impact on businesses
- Strategic Clarity: Enables leadership teams to convert primary evidence into clear decisions on launch and portfolio priority.
- Commercial Success: Provides the granular intelligence needed to move beyond national share figures to drive local market performance.
Why it may fit your brief
Its focus on primary, brand-specific research makes it an excellent choice for targeted strategic questions. For general public opinion or broad patient journey mapping, a wider-reaching consumer research firm might be more suitable.
AQR Fieldwork: best for specialized medical research recruitment and data collection
Strongest fitThis provider is best for specialized recruitment needs in challenging medical and B2B research segments.
AQR Fieldwork focuses on identifying and contacting specific audiences for healthcare and consumer research. The agency provides comprehensive support from participant recruitment to data analysis and reporting.
Its team is experienced in managing complex healthcare fieldwork, including IDIs, focus groups, and quantitative surveys. The firm emphasizes its ability to reach hard-to-find target groups through its proprietary panels and research partners.
Scorecard: 72.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 7/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 7/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | aqrfieldwork.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 72.0 |
Core services
- Participant Recruitment: Expert recruitment of niche target groups, including medical directors, pharmacy staff, and patients.
- Data Collection Services: Execution of CATI, CAPI, and online research methods to gather relevant project data.
- Analysis and Reporting: Processing of collected data to provide actionable insights tailored to specific research requirements.
Strengths
- Niche Targeting: Access to specialized target groups, including healthcare professionals, KOLs, and C-level executives.
- Fieldwork Expertise: Highly trained professionals with experience in managing complex, multi-stage healthcare projects.
- Methodological Variety: Wide range of data collection methods, including traditional telephone and modern online research tools.
Innovation and technology
- Complex CATI Solutions: Expertise in designing and conducting telephone interviews for difficult-to-reach audiences.
- Central Location Testing: Global experience in executing sensory and product testing in controlled environments.
Impact on businesses
- Actionable Insights: Translates research findings into clear, usable intelligence for marketing and commercial teams.
- Project Success: Supports the entire research process, making sure data collection aligns with specific project goals.
Why it may fit your brief
Its strength lies in finding specific niche audiences that broader panels might miss. For projects requiring large-scale, automated survey capacity, a firm with a larger technical infrastructure might be more efficient.
ARC Rynek i Opinia: best for long-term consumer and patient behavior tracking
Strongest fitThis provider is best for long-term tracking studies where consistency and a large, established panel are required.
ARC Rynek i Opinia is one of the largest independent research firms in Poland, offering comprehensive services for various sectors, including healthcare and pharmaceuticals. The firm operates its own online panel, ePanel.pl, which has been active for over two decades.
The agency uses modern CATI studios and CAWI platforms to deliver representative data for patient journey mapping and therapeutic preference studies.
Scorecard: 67.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 7/10 | arc.com.pl (5 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | arc.com.pl (5 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | arc.com.pl (5 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 7/10 | arc.com.pl (5 pages reviewed), Oct 2026 |
| Market Presence | 10 | 3/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | arc.com.pl (5 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | arc.com.pl (5 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | arc.com.pl (5 pages reviewed), Oct 2026 |
| Weighted score | 100 | 67.0 |
Core services
- Panel-Based Research: Access to a large, long-standing online panel for quantitative consumer and patient research.
- CATI Services: Professional telephone interviewing services conducted through dedicated, in-house facilities.
- Market Intelligence: Research support for market entry, product success evaluation, and trend analysis.
Strengths
- Long-Term Experience: Over three decades of market research experience with a deep understanding of the Polish consumer and patient environment.
- Large Panel Scale: Maintains ePanel.pl, one of the oldest and largest research panels in Poland, protecting reliable data collection.
- Quality Controls: Adherence to industry organizations and quality control programs, including PKJPA and PKJBI.
Innovation and technology
- Mobile-First Research: Optimized survey experiences for mobile devices, including a dedicated app for panelists.
- Integrated Platforms: Uses recognized CAWI software solutions to maintain consistency and speed in data collection.
Impact on businesses
- Risk Reduction: Helps minimize the risk of overlooking consumer needs, increasing the chances for product and service success.
- Intellectual Independence: Provides unbiased, research-based insights that move beyond stereotypes and marketing fads.
Why it may fit your brief
Its stability and long history provide a solid foundation for tracking patient attitudes over time. For highly specific medical studies requiring complex physician recruitment, a more medically specialized agency might offer deeper clinical access.
How HCP and patient verification actually works in Poland
Actionable verification requires a multi-step process matching professional credentials against official national registers.
Professional Credential Verification
For healthcare professionals in Poland, verification must involve checking the respondent against the official register of medical practitioners. A reputable provider will collect unique professional license numbers during the recruitment phase and perform cross-validation. You should ask for proof of this process as part of your initial project feasibility assessment to make sure you are not paying for generic survey respondents posing as clinical experts.
Digital Identity and Fingerprinting
Beyond manual credential checks, modern research relies on digital fingerprinting to make sure that one individual does not complete the same survey multiple times. This includes tracking IP addresses, device hardware identifiers, and browser characteristics. If a provider cannot explain their technical approach to preventing duplicate responses, the integrity of your longitudinal healthcare data may be at risk.
Behavioral Pattern Analysis
Automated systems should track how respondents work through through a questionnaire. Straight-lining, where a respondent selects the same answer for every question, and abnormally fast completion times are clear indicators of low-quality data. Effective agencies use these metrics to automatically flag or remove respondents before the data reaches your final analysis set, protecting the quality of your insights.
Rolling Re-validation Cycles
Healthcare panels are dynamic environments. A physician's specialty, practice setting, or status may change over time. The best providers conduct periodic re-validation, where they reach out to panel members to confirm their current practice and status. Ask your provider how often their panel is refreshed and what percentage of the data is re-verified, as stale data is a frequent contributor to poor project results.
How to choose the right provider in Poland
Focus on the specific research question to determine whether you need a specialist medical provider or a generalist agency.
- Define Research Objective: Determine if your study requires deep clinical insight or broad patient sentiment. Specialist medical agencies excel in the former, while large-scale firms handle the latter.
- Evaluate Panel Ownership: Prioritize providers that own their panels. This provides better control over data quality and protects consistent respondent behavior across longitudinal studies.
- Assess Compliance Capability: Make sure the provider has established protocols for adverse event reporting and data protection. This is non-negotiable for pharmaceutical research in Poland.
- Test Communication Speed: The responsiveness of an agency during the scoping phase is a strong indicator of their project management quality. Clear, quick communication is essential.
- Review Validation Methods: Ask for specific details on how they verify HCP credentials. A transparent, rigorous process is the best protection against poor data.
Questions to ask before you commission
- What specific databases or registries do you use to verify the credentials of Polish healthcare professionals?
- How does your agency handle the reporting of adverse events identified during the course of a market research study?
- Can you provide a breakdown of your panel size by specific medical specialty and region within Poland?
- What technical controls do you have in place to detect and remove bot activity or professional fraud in real-time?
- How do you manage the risk of over-surveying your panelists to maintain high engagement and data quality?
- What is your process for managing qualitative recruitment in challenging therapeutic areas where the target population is small?
Common pitfalls to avoid
- Over-reliance on Open Samples: Using open-market panels often leads to low data quality and professional misrepresentation. Always insist on proprietary, verified panels.
- Neglecting Local Regulation: Failing to align research with Polish data protection and healthcare ethical guidelines can cause significant delays. Make sure your partner knows the local environment.
- Ignoring Adverse Event Protocols: Medical research requires clear procedures for reporting product complaints or adverse events. Lack of these protocols is a major compliance risk.
- Poor Feasibility Planning: Assuming a target audience is easily reachable without checking incidence rates often results in project failure. Always demand an honest feasibility report.
What a feasibility check should include
A solid feasibility check must be data-driven, accounting for both audience size and the specific complexity of the study requirements.
Incidence Rate Analysis
A proper feasibility check estimates the percentage of the target population that qualifies for the study. This prevents unrealistic project timelines and budget overruns.
Specialty-Specific Availability
It must verify the number of active, reachable professionals within the exact therapeutic area requested. This is essential for niche studies where the target pool is limited.
Geographic Distribution
The check should assess if the required sample can be recruited across Poland or if it is concentrated in specific urban centers. This impacts fieldwork strategy and data representativeness.
Methodological Constraints
It must consider whether the chosen method, such as face-to-face or in-depth interview, is feasible for the target audience. Busy specialists may require more flexible, time-efficient methodologies.
Conclusion
Choosing the right partner for your research requires a careful balance between the breadth of a firm’s reach and the depth of its medical specialization. For large-scale studies where consistent methodology is essential, global firms provide solid infrastructure and standardisation. Conversely, for projects requiring deep clinical insight or niche recruitment, boutique agencies with established local networks and proprietary panels often deliver higher quality data.
Use the provided scorecard to evaluate each provider against your project’s unique requirements, paying close attention to their validation and compliance protocols. By prioritizing providers that offer transparency in their feasibility and data quality controls, you can mitigate risks and make sure that your insights are both accurate and actionable. Always request a detailed feasibility report before finalizing your partner to make sure their capabilities align with your strategic goals for the Polish market in 2026.
Planning research in Poland? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.
Frequently asked questions
How to find reliable healthcare market research panels in Poland?
Look for providers that own their proprietary panels rather than those using open-market exchanges. Ask for evidence of their credential verification process for physicians and nurses. Reliable firms will provide transparent information on their panel composition, validation frequency, and compliance with local data protection laws. Always perform a feasibility check to confirm they can reach your specific target audience.
What are the ethical requirements for medical research in Poland?
Medical research in Poland must adhere to the GDPR for data protection and specific local healthcare ethical guidelines. This includes securing granular, revocable consent from all participants. For pharmaceutical studies, providers must have established protocols for reporting adverse events and product complaints to the client. Agencies that follow ESOMAR or BHBIA codes typically demonstrate a high level of ethical alignment.
Which agencies conduct HCP surveys in Poland?
Several agencies, including Global Vox Populi, Kantar Polska, Ipsos Poland, Stratega Market Research, AQR Fieldwork, and BioNixus, conduct surveys among healthcare professionals in Poland. Each firm offers different strengths, ranging from large-scale global brand tracking to niche, account-level intelligence and localized qualitative recruitment. Your choice should depend on the specific scale, therapeutic area, and methodological complexity of your project.
How to reach medical specialists for research in Poland?
Reaching specialists requires accessing verified professional registries or communities. Specialist agencies use targeted outreach, including invitations via professional associations and verified medical databases. Because specialists are time-constrained, the recruitment strategy must offer a compelling value proposition and flexible participation options, such as online surveys or brief in-depth interviews, to protect high response rates.
What is the difference between a CRO and a market research agency in Poland?
A Contract Research Organization (CRO) typically focuses on clinical trials, regulatory approval, and drug development processes under strict clinical protocols. A market research agency, conversely, focuses on gathering insights into market dynamics, brand perception, prescribing habits, and patient behavior to inform commercial and marketing strategy. While both operate in the healthcare sector, their objectives and methodology differ significantly.
Are there specific regulations for pharmaceutical market research in Poland?
Yes, pharmaceutical market research is subject to strict regulations regarding patient data privacy and the ethical interaction with healthcare professionals. Researchers must comply with the GDPR and local healthcare laws. Also, industry-specific codes of conduct, such as those from the BHBIA, provide guidance on reporting adverse events and managing product safety information during the research process.
How does the Polish healthcare reimbursement system affect market research?
The Polish reimbursement system, often influenced by AOTMiT, is a critical factor for market access research. Studies frequently investigate payer willingness-to-pay and the criteria for drug inclusion on reimbursement lists. Understanding these dynamics is essential for pharmaceutical companies to design effective market access strategies, as research results directly impact commercial discussions with national and local health authorities.
What is the best way to validate HCP identities in Poland?
The most effective way to validate HCP identities is to cross-reference their professional license numbers against official medical and nursing registries. Reputable research agencies perform this check at the time of recruitment and maintain rolling re-validation programs to make sure panel data remains current. You should request that your research partner provides a transparent explanation of their specific validation methodology.